Inventor · disambiguated record
Samuel Hou
Also filed as: HOU SAMUEL
12 granted patents·4 pending applications·121 citations·filing 2009–2025
90Inventor score
Files withIchnos Sciences SA8GLENMARK PHARMACEUTICALS SA4ATTINGER ANTOINE1BLEIN STANISLAS1LAZARIDES ELIAS1
Top patents by PatentIndex Score
16 records- 0196US9493563B2Production of T cell retargeting hetero-dimeric immunoglobulinsGLENMARK PHARMACEUTICALS SA·Filed 2014·Granted Nov 15, 2016·47 cites·3 claims
- 0294US11891454B2Production of T cell retargeting hetero-dimeric immunoglobulinsIchnos Sciences SA·Filed 2020·Granted Feb 6, 2024·3 cites·15 claims
- 0392US8748585B2Antibodies that bind to OX40 and their usesATTINGER ANTOINE·Filed 2012·Granted Jun 10, 2014·36 cites·68 claims
- 0489US11773166B2CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their productionIchnos Sciences SA·Filed 2018·Granted Oct 3, 2023·5 cites·12 claims
- 0588US11851502B2Production of T cell retargeting hetero-dimeric immunoglobulinsIchnos Sciences SA·Filed 2018·Granted Dec 26, 2023·3 cites·13 claims
- 0685US8236315B2Humanized antibodies specific for von Willebrand factorLAZARIDES ELIAS·Filed 2009·Granted Aug 7, 2012·19 cites·126 claims
- 0782US11407839B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2019·Granted Aug 9, 2022·1 cites·30 claims
- 0882US8975376B2Anti-alpha2 integrin antibodies and their usesBLEIN STANISLAS·Filed 2011·Granted Mar 10, 2015·7 cites·14 claims
- 0981US12281169B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2022·Granted Apr 22, 2025·0 cites·28 claims
- 1077US2025250351A1Antibodies that bind to ox40 and their usesIchnos Sciences SA·Filed 2025·Application pending·0 cites
- 1172US12006367B2CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their productionIchnos Sciences SA·Filed 2022·Granted Jun 11, 2024·0 cites·9 claims
- 1262US2014294824A1Antibodies that bind to ox40 and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Application pending·0 cites
- 1361US2017145115A1Production of T cell retargeting hetero-dimeric immunoglobulinsGLENMARK PHARMACEUTICALS SA·Filed 2016·Application pending·0 cites
- 1458US2017260280A1Antibodies that Bind to OX40 and Their UsesGLENMARK PHARMACEUTICALS SA·Filed 2016·Application pending·0 cites
- 1546US11267891B2Fc variant antibodies and their usesSANOFI SA·Filed 2015·Granted Mar 8, 2022·0 cites·10 claims
- 1638US10640564B2Antibodies that bind to CCR6 and their usesIchnos Sciences SA·Filed 2015·Granted May 5, 2020·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →